Advancing Genomics in Cancer Care: From roadmap to realisation

Published Goran Duric on

This symposium brought together leaders in cancer care, research, policy and consumer advocacy to advance the integration of genomics into cancer care. Focused on collaboration, equity and implementation, it reviewed progress against the National Framework for Genomics in Cancer Control, showcased best-practice models, and identified opportunities to strengthen patient pathways and improve access to genomic services.

Through knowledge sharing and partnership building, the symposium aimed to equip the cancer workforce and lived experience advocates with the confidence and skills to embed genomics in oncology practice and accelerate better outcomes for all Australians.

Watch on demand

Symposium recording

The recording is published as seven sessions. Select a session to expand it and watch.

01 Welcome and opening 9 min

Professor David Ashley and Dr Kortnye Smith open From Roadmap to Realisation, outlining the urgent need to implement cancer genomics and precision medicine across Australia. They introduce the forum's focus on equitable access, stronger patient pathways, coordinated investment and improved cancer outcomes.

Runtime 9:13.

02 Integrating genomics into cancer care 1 hr 27 min

This session brings together lived-experience, policy, clinical and research perspectives on integrating genomics into cancer care across Australia. Speakers examine consumer awareness and access to tumour genomic profiling, national policy and implementation initiatives, Omico's work to expand equitable access to precision oncology, and the clinical potential of whole-genome sequencing and liquid biopsy.

Runtime 1:26:30.

03 Strengthening patient pathways 26 min

In Strengthening Patient Pathways, the session examines clinician- and patient-level barriers to effectively integrating genomic testing into cancer care, including gaps in clinician knowledge and confidence, complex consent discussions, inconsistent reporting and patients' limited understanding of results. It explores practical responses including ongoing case-based education, co-designed decision-support resources, molecular tumour boards, clearer communication, and careful management of germline findings and genomic data.

Runtime 26:00.

04 Equity in genomics: regional and rural access 52 min

Focused on equity in genomics, this session examines access to genomic profiling and precision oncology for people living in regional and rural Australia. It combines Omico data, Amelia James's lived experience of genomics-informed treatment, and clinical perspectives on overcoming barriers to matched therapies through local champions, decentralised trials and collaborative trial networks.

Runtime 51:45.

05 Equity in genomics: Aboriginal and Torres Strait Islander communities 22 min

This session looks at understanding and addressing equity in genomics, including current barriers and opportunities for Aboriginal and Torres Strait Islander people. It covers underrepresentation in cancer clinical trials, financial toxicity, clinician bias, endemic racism in health and research systems, cultural safety, Indigenous data sovereignty, and culturally informed practices, governance and research.

Runtime 22:14.

06 Accelerating precision oncology through technology 42 min

This session discusses accelerating precision oncology through technology, focusing on the implementation gap, sustainable and adequate funding, data connectivity, workforce education, equitable access and the use of artificial intelligence to support decision-making at scale.

Runtime 42:13.

07 Closing statements 2 min

Closing reflections on the need to work as a team to move genomics forward, followed by thanks to everyone who contributed to the symposium.

Runtime 1:39.

At a glance

The symposium in brief

Originally held

Friday 7 August 2026, 9.00am–3.45pm AEST

Lecture Theatre B, Peter MacCallum Cancer Centre, and online.

Who this is for

Healthcare professionals and leaders in cancer care

Healthcare professionals and leaders in cancer care, research, policy, and consumer advocacy.

Objectives

—  Unite leaders in cancer care, research, policy, and consumer advocacy
—  Review progress and align initiatives with the National Framework for Genomics in Cancer Control
—  Strengthen patient pathways and addressing equity for all populations
—  Equip clinicians with the knowledge and skills to confidently integrate genomics into oncology practice

Outcomes

—  Share priorities identified to accelerate implementation of the Roadmap to Precision Oncology in line with the National Framework for Genomics in Cancer Control
—  Best-practice models showcased to strengthen coordination and patient pathways
—  Barriers and opportunities identified to improve genomic access for Aboriginal and Torres Strait Islander peoples, rural, and regional communities
—  Stronger national partnerships established to drive continuous improvement and knowledge exchange

Contributors

Convenor and speakers

Dr Kortnye Smith

Convenor

Dr Kortnye Smith

Medical oncologist and researcher, Peter MacCallum Cancer Centre and Eastern Health

After completing her medical oncology training, Dr Smith pursued a two-year fellowship at Peter MacCallum Cancer Centre and the Melbourne Genomic Health Alliance where she investigated genomic sequencing in cancer therapy. Kortnye works mainly in lung cancer and melanoma as well as focusing on her passion to improve patient equity by coordinating the Oncology in the Home program in Melbourne.

Speakers

Prof David Ashley

Chief Executive Officer VCCC Alliance, Laboratory Head, Walter and Eliza Hall Institute - The Brain Cancer Centre; Neuro-oncologist, Peter MacCallum Centre

Prof Vivienne Milch

Medical Director and Head, Clinical Policy Advice Branch, Cancer Australia

Kathy Minas

Lived experience leader and advocate

Tiffany Boughtwood

Australian Health Genomics Commissioner

Dr Damien Kee

Deputy Chair, Omico Molecular Oncology Board; Medical Oncologist, Austin Health and Peter MacCallum Cancer Centre; Research Fellow, Walter Eliza Hall Institute

Prof Sean Grimmond

Director, Collaborative Centre for Cancer Genomics, Centre for Cancer Research

A/Prof Alison Trainer

Peter MacCallum Cancer Centre

Louise Lyons

Senior Manager, Strategy and Policy, Australian Alliance for Indigenous Genomics; VCCC Alliance Aboriginal and Torres Strait Islander Health Research and Education Co-Lead

Melissa Sheldon

Lived experience leader and advocate

Leah Lindrea-Morrison

Lotjpa Yapaneyepuk – Talk Together

Dr Samuel Harris

Medical Oncologist, Bendigo Regional Cancer Centre, Bendigo Health; Regional and Rural Research and Education Lead, VCCC Alliance

Amelia James

Lived experience leader and advocate

Dr Malaka Ameratunga

Medical Oncologist, Bayside Health, MPCCC

Endorsed by

Partners


AstraZeneca and Moderna provided financial support for this event. Content was developed independently by the VCCC Alliance and the presenting faculty.

Resource details

A laboratory scientist examining a sample tube beside a translucent DNA strand.
Course type
Webinars
Duration
4 hrs
Price
$0.00
Curriculum Area
Prevention, screening and diagnostics
Treatment (incl. Supportive Care)
Research (incl. Clinical Trials)
Clinical Care
Speciality
Clinical trials
Clinician
Consumer / patient / carer
Early to mid career researcher
Nurse
Senior researcher / scientist
Aboriginal and Torres Strait Islander
Clinical trials
Equity and inclusion
Genomics
Precision medicine
Precision oncology
Regional
Targeted therapy

This course is brought to you by

Alliance members